Skip to Main content Skip to Navigation
Journal articles

The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines

Abstract : Multiple myeloma (MM) is an incurable hematological malignancy for which new therapeutic strategies should be envisaged. The selective estrogen receptor modulator (SERM), 4-hydroxy tamoxifen (4-OHTam), in the range of 1 to 10 micro M, was able to impair the cell proliferation of MM cell lines. This was achieved by blocking cells at the G1 phase of the cell cycle and by inducing apoptosis. This cellular response was observed in five out of six tested cell lines, all five expressing both alpha and beta estrogen receptor forms. No modifications of Bcl-2, Bcl-X, and Bax levels were observed, as well as no changes in Pi3K/Akt and JAK/STAT pathways that are often constitutively active in these cells. The signalization of 4-OHTam-induced cell death needs further investigation.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-tours.archives-ouvertes.fr/hal-02427345
Contributor : Fabrice Gouilleux <>
Submitted on : Friday, January 3, 2020 - 3:02:59 PM
Last modification on : Monday, January 6, 2020 - 4:02:24 PM

Links full text

Identifiers

Citation

Juliette Gauduchon, Fabrice Gouilleux, Sébastien Maillard, Véronique Marsaud, Michel Renoir, et al.. The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines. Annals of the New York Academy of Sciences, Wiley, 2003, 1010 (1), pp.321-325. ⟨10.1196/annals.1299.057⟩. ⟨hal-02427345⟩

Share

Metrics

Record views

36